Proteinmaxxing Trend May Drive Up Infant Formula Prices 2026

Proteinmaxxing, a trend where consumers maximize protein intake, is now linked to potential price hikes in infant formula. As whey protein demand surges, experts warn that families may face higher costs for essential baby nutrition.

Why Proteinmaxxing Affects Infant Formula Costs

The fitness and wellness movement has popularized high-protein diets, increasing the consumption of whey protein supplements. This surge in demand directly impacts the price of whey protein concentrate, a critical ingredient in infant formula. Manufacturers now compete with the sports nutrition industry for the same raw materials.

Additionally, the rise of GLP-1 weight-loss medications has amplified protein consumption. Users of these drugs often rely on protein shakes to preserve muscle mass, further straining whey supply. This dual demand has led to unprecedented price increases in the whey market.

Whey Protein Price Surge

According to Expana, a global market intelligence platform, the price of whey protein concentrate 80 (with 80% pure protein) skyrocketed from €11,733 per metric tonne in July 2025 to €25,875 recently. This dramatic rise is a direct consequence of proteinmaxxing and related trends.

Impact on Infant Formula Prices

Infant formula relies heavily on whey protein to mimic breast milk and aid digestion in newborns. As whey costs climb, manufacturers face a choice: absorb the cost or pass it to consumers. Historical data from the Competition and Markets Authority (CMA) shows that formula makers typically pass on input cost increases.

Recent Office for National Statistics data reveals that the average price of baby formula has already risen by 4.8% over the past year, with a 750g box now costing £12.11. Experts warn this trend may accelerate if whey prices remain elevated.

Expert Concerns

Dr Vicky Sibson, director of the First Steps Nutrition Trust, expressed deep concern: “Whey is a major ingredient in infant formula, so significant increases in its price risk increasing the price of formula itself.” She noted that families already struggle to afford formula, and further hikes could worsen the situation.

The CMA’s report indicates that manufacturers have historically passed on cost increases during crises, making it likely that consumers will bear the brunt of this whey price surge. This could push more families into financial distress, affecting infant health and well-being.

Key Takeaways

• Proteinmaxxing and GLP-1 drug use are driving whey protein demand and prices.
• Infant formula prices have already risen 4.8% year-over-year, with more increases possible.
• Manufacturers are likely to pass on higher ingredient costs to consumers.
• Families may need to explore support options or alternative feeding methods.

FAQ